Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Istituto Biochimico Italiano
Aprilia, Lazio, Italy
- Ownership
- Private
- Employees
- ~330
- Development stage
- Other
01
Overview
IBI is one of Italy's top contract manufacturers for injectables, notably β-lactam antibiotics, also developing innovative biological formulations such as nanoparticles, and has received FDA approval for sterile penicillin production for the US market
- Therapeutic areas
- Infectious DiseasesOther
- Modalities
- Small moleculeBiologicNanoparticleRecombinant proteinβ-lactam antibioticsInjectable formulations
- Industry
- Contract Manufacturing Organization
02
Partnerships
Distribution partnerships in Italy, UK, Germany, Ireland via Ibisqus Hospital Lineglobal contract manufacturing clients
Beyond the preview
Go deeper on Istituto Biochimico Italiano.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Istituto Biochimico Italiano.